Tuomilehto J - Search Results

1

The emerging global epidemic of type 1 diabetes.

Tuomilehto J. Tuomilehto J. Curr Diab Rep. 2013 Dec;13(6):795-804. doi: 10.1007/s11892-013-0433-5. Curr Diab Rep. 2013. PMID: 24072479

2

A demonstration area for type 2 diabetes prevention in Barranquilla and Juan Mina (Colombia): Baseline characteristics of the study participants.

Acosta T, Barengo NC, Arrieta A, Ricaurte C, Tuomilehto JO. Acosta T, et al. Medicine (Baltimore). 2018 Jan;97(1):e9285. doi: 10.1097/MD.0000000000009285. Medicine (Baltimore). 2018. PMID: 29505512 Free PMC article. Clinical Trial.

3

Screening for people with abnormal glucose metabolism in the European DE-PLAN project.

Cos FX, Barengo NC, Costa B, Mundet-Tudurí X, Lindström J, Tuomilehto JO; DE-PLAN Study Group. Cos FX, et al. Among authors: tuomilehto jo. Diabetes Res Clin Pract. 2015 Jul;109(1):149-56. doi: 10.1016/j.diabres.2015.04.016. Epub 2015 Apr 20. Diabetes Res Clin Pract. 2015. PMID: 25931281

4

Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.

Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Puolijoki H, Tuomilehto J, Vanhala M, Moilanen L, Uusitupa M, Keinänen-Kiukaanniemi S. Rautio N, et al. Among authors: tuomilehto j. Diabet Med. 2015 Dec;32(12):1611-6. doi: 10.1111/dme.12776. Epub 2015 May 8. Diabet Med. 2015. PMID: 25864699

5

Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study.

Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, Sulkava R, Kivipelto M. Ahtiluoto S, et al. Among authors: tuomilehto j. Neurology. 2010 Sep 28;75(13):1195-202. doi: 10.1212/WNL.0b013e3181f4d7f8. Epub 2010 Aug 25. Neurology. 2010. PMID: 20739645

6

A review of the efficacy of rosuvastatin in patients with type 2 diabetes.

Tuomilehto J, Leiter LA, Kallend D. Tuomilehto J, et al. Int J Clin Pract Suppl. 2004 Oct;(143):30-40. doi: 10.1111/j.1368-504x.2004.00390.x. Int J Clin Pract Suppl. 2004. PMID: 16035394 Review.

7

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group. Tuomilehto J, et al. N Engl J Med. 2001 May 3;344(18):1343-50. doi: 10.1056/NEJM200105033441801. N Engl J Med. 2001. PMID: 11333990 Clinical Trial.

8

Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes.

Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J. Bidel S, et al. Among authors: tuomilehto j. Eur J Clin Nutr. 2008 Feb;62(2):178-85. doi: 10.1038/sj.ejcn.1602712. Epub 2007 Mar 7. Eur J Clin Nutr. 2008. PMID: 17342160

9

Ultrasonographic manifestations of carotid atherosclerosis and glucose intolerance in elderly eastern Finnish men.

Tuomilehto J, Qiao Q, Salonen R, Nissinen A, Salonen JT. Tuomilehto J, et al. Diabetes Care. 1998 Aug;21(8):1349-52. doi: 10.2337/diacare.21.8.1349. Diabetes Care. 1998. PMID: 9702446

10

Markers of cholesterol metabolism as biomarkers in predicting diabetes in the Finnish Diabetes Prevention Study.

de Mello VD, Lindström J, Eriksson JG, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Pihlajamäki J, Tuomilehto J, Uusitupa M. de Mello VD, et al. Among authors: tuomilehto j. Nutr Metab Cardiovasc Dis. 2015 Jul;25(7):635-42. doi: 10.1016/j.numecd.2015.03.012. Epub 2015 Mar 28. Nutr Metab Cardiovasc Dis. 2015. PMID: 25921846 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results